The prophet Amos condemns the Ammonites "because they ripped open expectant mothers in Gilead" (Amos 1:13). "Truly children are a gift from the Lord; the fruit of the womb is a reward" (Psalm 127:3).

Margaret Atwood’s chilling world of Gilead returns in The Testaments, the long-anticipated sequel to her groundbreaking novel ...

Gilead (GILD) announced topline results from the Phase 3 ASCENT-03 study of Trodelvy.The study met its primary endpoint, demonstrating a highly statistically significant and clinically meaningful ...

Despite a sharp decline in sales of COVID-19 blockbuster Veklury, Gilead Sciences once again beat consensus revenue and EPS forecasts. The drugs whose performance impressed me greatly in Q1 2025 ...

Spoiler alert! This story contains details from the series finale of "The Handmaid's Tale." Gilead hasn't fallen quite yet, but June Osborne will keep fighting however she can. The quiet ...

Matthew Herper covers medical innovation — both its promise and its perils. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business ...

After meeting the mark alongside Keytruda in PD-L1-positive breast cancer earlier this year, Gilead Sciences' antibody-drug conjugate Trodelvy has impressed in a solo showing in a similar indication.

Ratings for Gilead Sciences GILD were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings ...

Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical powerhouse known for its innovative HIV treatments, is navigating a complex landscape of opportunities and challenges as it seeks to ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...

Gilead and Merck combo's breast cancer win — The popular drug Trodelvy from Gilead in combination with Merck's blockbuster immunotherapy Keytruda lowered the risk of an aggressive type of breast ...